17:40 , Nov 15, 2016 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Brain cancer Patient sample, cell culture and mouse studies suggest inhibiting FOXD1 or ALDH1A3 could help treat glioma. In patients, high tumor expression of FOXD1 or ALDH1A3 was associated with poor survival. In human...